Home Biosimilar Antibodies Metabolism PCSK9 antibody Bococizumab (Anti-PCSK9) For research use only.
Not for use in humans.

Bococizumab (Anti-PCSK9)

Synonyms: PF-04950615; RN316

Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.

Bococizumab (Anti-PCSK9)

Purity & Quality Control

Batch: A278801 Purity: 99% Protein concentration: 6.18mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective PCSK9 Inhibitors

Biological Activity

Description Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.

Product Details

CAS No. 1407495-02-6
Molecular Weight 145.06
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Bococizumab (Anti-PCSK9) | Bococizumab (Anti-PCSK9) supplier | purchase Bococizumab (Anti-PCSK9) | Bococizumab (Anti-PCSK9) cost | Bococizumab (Anti-PCSK9) manufacturer | order Bococizumab (Anti-PCSK9) | Bococizumab (Anti-PCSK9) distributor